APO Research
Talk to an analyst

APO RESEARCH · REPORT

Alimta

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Alimta Industry Growth and Trends Forecast to 2032

22 December 202570 pages

Choose your research edition.

Industry ResearchAlimta Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Alimta Industry Growth and Trends Forecast to 203270 pages · $3,450 USDMarket StructureGlobal Alimta Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032179 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Alimta Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Alimta Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Alimta market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Alimta is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Alimta is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Alimta is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Alimta include Eagle Pharmaceuticals, Eli Lilly, Cadila Healthcare and Abbott Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Alimta market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Alimta market size, estimates, and forecasts are presented in terms of sales volume (kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Alimta market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Alimta.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Alimta market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Alimta Market by Company

Eagle Pharmaceuticals

Eli Lilly

Cadila Healthcare

Abbott Healthcare

Alimta Segment by Type

100mg

500mg

Alimta Segment by Application

Pleural Mesothelioma

Non-small Cell Lung Cancer

Alimta Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alimta market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Alimta and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alimta.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Alimta manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Alimta in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 100mg Table 2. Major Company of 500mg Table 3. Global Alimta Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Alimta Sales by Type (2021-2026) & (kg) Table 5. Global Alimta Sales Market Share in Volume by Type (2021-2026) Table 6. Global Alimta Sales by Type (2021-2026) & (US$ Million) Table 7. Global Alimta Sales Market Share in Value by Type (2021-2026) Table 8. Global Alimta Price by Type (2021-2026) & (US$/g) Table 9. Global Alimta Sales by Type (2027-2032) & (kg) Table 10. Global Alimta Sales Market Share in Volume by Type (2027-2032) Table 11. Global Alimta Sales by Type (2027-2032) & (US$ Million) Table 12. Global Alimta Sales Market Share in Value by Type (2027-2032) Table 13. Global Alimta Price by Type (2027-2032) & (US$/g) Table 14. North America Alimta Sales by Type (2021-2026) & (kg) Table 15. North America Alimta Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Alimta Sales by Type (2021-2026) & (kg) Table 17. Europe Alimta Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Alimta Sales by Type (2021-2026) & (kg) Table 19. Asia-Pacific Alimta Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Alimta Sales by Type (2021-2026) & (kg) Table 21. Latin America Alimta Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Alimta Sales by Type (2021-2026) & (kg) Table 23. Middle East and Africa Alimta Sales by Type (2021-2026) & (US$ Million) Table 24. Alimta Industry Trends Table 25. Alimta Industry Drivers Table 26. Alimta Industry Opportunities and Challenges Table 27. Alimta Industry Restraints Table 28. Global Alimta Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Alimta Revenue Market Share by Company (2021-2026) Table 30. Global Alimta Sales by Company (2021-2026) & (kg) Table 31. Global Alimta Sales Share by Company (2021-2026) Table 32. Global Alimta Market Price by Company (2021-2026) & (US$/g) Table 33. Global Alimta Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Alimta Major Company Production Sites and Headquarters Table 35. Global Alimta Company, Product Type & Application Table 36. Global Alimta Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Alimta by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Alimta Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Alimta Sales by Region (2021-2026) & (kg) Table 41. Global Alimta Sales Market Share in Volume by Region (2021-2026) Table 42. Global Alimta Sales by Region (2021-2026) & (US$ Million) Table 43. Global Alimta Sales Market Share in Value by Region (2021-2026) Table 44. Global Alimta Sales (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 45. Global Alimta Sales by Region (2027-2032) & (kg) Table 46. Global Alimta Sales Market Share in Volume by Region (2027-2032) Table 47. Global Alimta Sales by Region (2027-2032) & (US$ Million) Table 48. Global Alimta Sales Market Share in Value by Region (2027-2032) Table 49. Global Alimta Sales (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2027-2032) Table 50. Global Alimta Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Alimta Sales by Application (2021-2026) & (kg) Table 52. Global Alimta Sales Market Share in Volume by Application (2021-2026) Table 53. Global Alimta Sales by Application (2021-2026) & (US$ Million) Table 54. Global Alimta Sales Market Share in Value by Application (2021-2026) Table 55. Global Alimta Price by Application (2021-2026) & (US$/g) Table 56. Global Alimta Sales by Application (2027-2032) & (kg) Table 57. Global Alimta Sales Market Share in Volume by Application (2027-2032) Table 58. Global Alimta Sales by Application (2027-2032) & (US$ Million) Table 59. Global Alimta Sales Market Share in Value by Application (2027-2032) Table 60. Global Alimta Price by Application (2027-2032) & (US$/g) Table 61. North America Alimta Sales by Application (2021-2026) & (kg) Table 62. North America Alimta Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Alimta Sales by Application (2021-2026) & (kg) Table 64. Europe Alimta Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Alimta Sales by Application (2021-2026) & (kg) Table 66. Asia-Pacific Alimta Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Alimta Sales by Application (2021-2026) & (kg) Table 68. Latin America Alimta Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Alimta Sales by Application (2021-2026) & (kg) Table 70. Middle East and Africa Alimta Sales by Application (2021-2026) & (US$ Million) Table 71. Eagle Pharmaceuticals Company Information Table 72. Eagle Pharmaceuticals Business Overview Table 73. Eagle Pharmaceuticals Alimta Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 74. Eagle Pharmaceuticals Alimta Product Portfolio Table 75. Eagle Pharmaceuticals Recent Development Table 76. Eli Lilly Company Information Table 77. Eli Lilly Business Overview Table 78. Eli Lilly Alimta Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 79. Eli Lilly Alimta Product Portfolio Table 80. Eli Lilly Recent Development Table 81. Cadila Healthcare Company Information Table 82. Cadila Healthcare Business Overview Table 83. Cadila Healthcare Alimta Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 84. Cadila Healthcare Alimta Product Portfolio Table 85. Cadila Healthcare Recent Development Table 86. Abbott Healthcare Company Information Table 87. Abbott Healthcare Business Overview Table 88. Abbott Healthcare Alimta Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 89. Abbott Healthcare Alimta Product Portfolio Table 90. Abbott Healthcare Recent Development Table 91. North America Alimta Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 92. North America Alimta Sales by Country (2021-2026) & (kg) Table 93. North America Alimta Sales Market Share by Country (2021-2026) Table 94. North America Alimta Sales Forecast by Country (2027-2032) & (kg) Table 95. North America Alimta Sales Market Share Forecast by Country (2027-2032) Table 96. North America Alimta Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 97. North America Alimta Market Size by Country (2021-2026) & (US$ Million) Table 98. North America Alimta Market Share by Country (2021-2026) Table 99. North America Alimta Market Size Forecast by Country (2027-2032) & (US$ Million) Table 100. North America Alimta Market Share Forecast by Country (2027-2032) Table 101. Europe Alimta Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 102. Europe Alimta Sales by Country (2021-2026) & (kg) Table 103. Europe Alimta Sales Market Share by Country (2021-2026) Table 104. Europe Alimta Sales Forecast by Country (2027-2032) & (kg) Table 105. Europe Alimta Sales Market Share Forecast by Country (2027-2032) Table 106. Europe Alimta Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. Europe Alimta Market Size by Country (2021-2026) & (US$ Million) Table 108. Europe Alimta Market Share by Country (2021-2026) Table 109. Europe Alimta Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. Europe Alimta Market Share Forecast by Country (2027-2032) Table 111. Asia-Pacific Alimta Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 112. Asia-Pacific Alimta Sales by Country (2021-2026) & (kg) Table 113. Asia-Pacific Alimta Sales Market Share by Country (2021-2026) Table 114. Asia-Pacific Alimta Sales Forecast by Country (2027-2032) & (kg) Table 115. Asia-Pacific Alimta Sales Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific Alimta Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific Alimta Market Size by Country (2021-2026) & (US$ Million) Table 118. Asia-Pacific Alimta Market Share by Country (2021-2026) Table 119. Asia-Pacific Alimta Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Asia-Pacific Alimta Market Share Forecast by Country (2027-2032) Table 121. Latin America Alimta Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 122. Latin America Alimta Sales by Country (2021-2026) & (kg) Table 123. Latin America Alimta Sales Market Share by Country (2021-2026) Table 124. Latin America Alimta Sales Forecast by Country (2027-2032) & (kg) Table 125. Latin America Alimta Sales Market Share Forecast by Country (2027-2032) Table 126. Latin America Alimta Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Latin America Alimta Market Size by Country (2021-2026) & (US$ Million) Table 128. Latin America Alimta Market Share by Country (2021-2026) Table 129. Latin America Alimta Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Latin America Alimta Market Share Forecast by Country (2027-2032) Table 131. Middle East and Africa Alimta Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 132. Middle East and Africa Alimta Sales by Country (2021-2026) & (kg) Table 133. Middle East and Africa Alimta Sales Market Share by Country (2021-2026) Table 134. Middle East and Africa Alimta Sales Forecast by Country (2027-2032) & (kg) Table 135. Middle East and Africa Alimta Sales Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa Alimta Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa Alimta Market Size by Country (2021-2026) & (US$ Million) Table 138. Middle East and Africa Alimta Market Share by Country (2021-2026) Table 139. Middle East and Africa Alimta Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Middle East and Africa Alimta Market Share Forecast by Country (2027-2032) Table 141. Key Raw Materials Table 142. Raw Materials Key Suppliers Table 143. Alimta Distributors List Table 144. Alimta Customers List Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. Alimta Image Figure 2. Global Alimta Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Alimta Market Size (2021-2032) & (US$ Million) Figure 4. Global Alimta Sales (2021-2032) & (kg) Figure 5. 100mg Image Figure 6. Global 100mg Sales YoY Growth (2021-2032) & (kg) Figure 7. 500mg Image Figure 8. Global 500mg Sales YoY Growth (2021-2032) & (kg) Figure 9. Global Alimta Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Alimta Market Share by Type 2025 VS 2032 Figure 11. North America Alimta Sales Market Share in Volume by Type in 2025 Figure 12. North America Alimta Sales Market Share in Value by Type in 2025 Figure 13. Europe Alimta Sales Market Share in Volume by Type in 2025 Figure 14. Europe Alimta Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Alimta Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Alimta Sales Market Share in Value by Type in 2025 Figure 17. Latin America Alimta Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Alimta Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Alimta Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Alimta Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Alimta Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Pleural Mesothelioma Image Figure 24. Global Pleural Mesothelioma Sales YoY Growth (2021-2032) & (kg) Figure 25. Non-small Cell Lung Cancer Image Figure 26. Global Non-small Cell Lung Cancer Sales YoY Growth (2021-2032) & (kg) Figure 27. Global Alimta Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Alimta Market Share by Application 2025 VS 2032 Figure 29. North America Alimta Sales Market Share in Volume by Application in 2025 Figure 30. North America Alimta Sales Market Share in Value by Application in 2025 Figure 31. Europe Alimta Sales Market Share in Volume by Application in 2025 Figure 32. Europe Alimta Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Alimta Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Alimta Sales Market Share in Value by Application in 2025 Figure 35. Latin America Alimta Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Alimta Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Alimta Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Alimta Sales Market Share in Value by Application in 2025 Figure 39. North America Alimta Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 40. North America Alimta Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Alimta Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Alimta Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Alimta Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 44. Europe Alimta Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Alimta Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Alimta Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Alimta Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 48. Asia-Pacific Alimta Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Alimta Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Alimta Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Alimta Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 52. Latin America Alimta Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Alimta Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Alimta Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Alimta Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 56. Middle East and Africa Alimta Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Alimta Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Alimta Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Alimta Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Alimta Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • 100mg
  • 500mg
Applications
  • Pleural Mesothelioma
  • Non-small Cell Lung Cancer
Companies covered
  • Eagle Pharmaceuticals
  • Eli Lilly
  • Cadila Healthcare
  • Abbott Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Alimta Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Alimta Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Alimta Market by Type
  6. 1.3.1 100mg
  7. 1.3.2 500mg
  8. 1.4 Global Alimta Market Size by Type
  9. 1.4.1 Global Alimta Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Alimta Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Alimta Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Alimta Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Alimta Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Alimta Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Alimta Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Alimta Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Alimta Industry Trends
  2. 2.2 Alimta Industry Drivers
  3. 2.3 Alimta Industry Opportunities and Challenges
  4. 2.4 Alimta Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Alimta Revenue (2021-2026)
  2. 3.2 Global Top Players by Alimta Sales (2021-2026)
  3. 3.3 Global Top Players by Alimta Price (2021-2026)
  4. 3.4 Global Alimta Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Alimta Major Company Production Sites & Headquarters
  6. 3.6 Global Alimta Company, Product Type & Application
  7. 3.7 Global Alimta Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Alimta Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Alimta Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Alimta Tier 1, Tier 2, and Tier 3
4 Alimta Regional Status and Outlook
  1. 4.1 Global Alimta Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Alimta Historic Market Size by Region
  3. 4.2.1 Global Alimta Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Alimta Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Alimta Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Alimta Forecasted Market Size by Region
  7. 4.3.1 Global Alimta Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Alimta Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Alimta Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Alimta by Application
  1. 5.1 Alimta Market by Application
  2. 5.1.1 Pleural Mesothelioma
  3. 5.1.2 Non-small Cell Lung Cancer
  4. 5.2 Global Alimta Market Size by Application
  5. 5.2.1 Global Alimta Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Alimta Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Alimta Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Alimta Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Alimta Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Alimta Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Alimta Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Alimta Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Eagle Pharmaceuticals
  2. 6.1.1 Eagle Pharmaceuticals Company Information
  3. 6.1.2 Eagle Pharmaceuticals Business Overview
  4. 6.1.3 Eagle Pharmaceuticals Alimta Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Eagle Pharmaceuticals Alimta Product Portfolio
  6. 6.1.5 Eagle Pharmaceuticals Recent Developments
  7. 6.2 Eli Lilly
  8. 6.2.1 Eli Lilly Company Information
  9. 6.2.2 Eli Lilly Business Overview
  10. 6.2.3 Eli Lilly Alimta Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Eli Lilly Alimta Product Portfolio
  12. 6.2.5 Eli Lilly Recent Developments
  13. 6.3 Cadila Healthcare
  14. 6.3.1 Cadila Healthcare Company Information
  15. 6.3.2 Cadila Healthcare Business Overview
  16. 6.3.3 Cadila Healthcare Alimta Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Cadila Healthcare Alimta Product Portfolio
  18. 6.3.5 Cadila Healthcare Recent Developments
  19. 6.4 Abbott Healthcare
  20. 6.4.1 Abbott Healthcare Company Information
  21. 6.4.2 Abbott Healthcare Business Overview
  22. 6.4.3 Abbott Healthcare Alimta Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Abbott Healthcare Alimta Product Portfolio
  24. 6.4.5 Abbott Healthcare Recent Developments
7 North America by Country
  1. 7.1 North America Alimta Sales by Country
  2. 7.1.1 North America Alimta Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Alimta Sales by Country (2021-2026)
  4. 7.1.3 North America Alimta Sales Forecast by Country (2027-2032)
  5. 7.2 North America Alimta Market Size by Country
  6. 7.2.1 North America Alimta Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Alimta Market Size by Country (2021-2026)
  8. 7.2.3 North America Alimta Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Alimta Sales by Country
  2. 8.1.1 Europe Alimta Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Alimta Sales by Country (2021-2026)
  4. 8.1.3 Europe Alimta Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Alimta Market Size by Country
  6. 8.2.1 Europe Alimta Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Alimta Market Size by Country (2021-2026)
  8. 8.2.3 Europe Alimta Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Alimta Sales by Country
  2. 9.1.1 Asia-Pacific Alimta Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Alimta Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Alimta Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Alimta Market Size by Country
  6. 9.2.1 Asia-Pacific Alimta Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Alimta Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Alimta Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Alimta Sales by Country
  2. 10.1.1 South America Alimta Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Alimta Sales by Country (2021-2026)
  4. 10.1.3 South America Alimta Sales Forecast by Country (2027-2032)
  5. 10.2 South America Alimta Market Size by Country
  6. 10.2.1 South America Alimta Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Alimta Market Size by Country (2021-2026)
  8. 10.2.3 South America Alimta Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Alimta Sales by Country
  2. 11.1.1 Middle East and Africa Alimta Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Alimta Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Alimta Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Alimta Market Size by Country
  6. 11.2.1 Middle East and Africa Alimta Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Alimta Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Alimta Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Alimta Value Chain Analysis
  2. 12.1.1 Alimta Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Alimta Production Mode & Process
  7. 12.2 Alimta Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Alimta Distributors
  10. 12.2.3 Alimta Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst